Intracellular mechanisms mediating the neuronal death and astrogliosis induced by the prion protein fragment 106–126
- 15 May 2000
- journal article
- Published by Wiley in International Journal of Developmental Neuroscience
- Vol. 18 (4-5) , 481-492
Abstract
Prion encephalopathies include fatal diseases of the central nervous system of men and animals characterized by nerve cell loss, glial proliferation and deposition of amyloid fibrils into the brain. During these diseases a cellular glycoprotein (the prion protein, PrPC) is converted, through a not yet completely clear mechanism, in an altered isoform (the prion scrapie, PrPSc) that accumulates within the brain tissue by virtue of its resistance to the intracellular catabolism. PrPSc is believed to be responsible for the neuronal loss that is observed in the prion disease. The PrP 106–126, a synthetic peptide that has been obtained from the amyloidogenic portion of the prion protein, represents a suitable model for studying the pathogenic role of the PrPSc, retaining, in vitro, some characteristics of the entire protein, such as the capability to aggregate in fibrils, and the neurotoxicity. In this work we present the results we have recently obtained regarding the action of the PrP 106–126 in different cellular models. We report that the PrP 106–126 induces proliferation of cortical astrocytes, as well as degeneration of primary cultures of cortical neurons or of neuroectodermal stable cell lines (GH3 cells). In particular, these two opposite effects are mediated by the same attitude of the peptide to interact with the L‐type calcium channels: in the astrocytes, the activity of these channels seems to be activated by PrP 106–126, while, in the cortical neurons and in the GH3 cells, the same treatment causes a blockade of these channels causing a toxic effect.Keywords
Funding Information
- Fondazione Telethon (E.394)
This publication has 44 references indexed in Scilit:
- Autonomous and Reversible Folding of a Soluble Amino-terminally Truncated Segment of the Mouse Prion ProteinJournal of Molecular Biology, 1996
- Prion Protein AmyloidosisBrain Pathology, 1996
- Truncated Forms of the Human Prion Protein in Normal Brain and in Prion DiseasesJournal of Biological Chemistry, 1995
- A Neurotoxic Prion Protein Fragment Induces Rat Astroglial Proliferation and HypertrophyEuropean Journal of Neuroscience, 1994
- Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell culturesEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Molecular Characteristics of a Protease-Resistant, Amyloidogenic and Neurotoxic Peptide Homologous to Residues 106-126 of the Prion ProteinBiochemical and Biophysical Research Communications, 1993
- Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencingBiochemistry, 1993
- Chemistry and biology of prionsBiochemistry, 1992
- Voltage‐dependent calcium channels regulate GH4 pituitary cell proliferation at two stages of the cell cycleJournal of Cellular Physiology, 1991
- Fatal Familial Insomnia and Dysautonomia with Selective Degeneration of Thalamic NucleiNew England Journal of Medicine, 1986